Lam Research Corporation March quarter 2022 financial results April 20, 2022 -- 1 of 24 -- L A M R E S E A R C H Cautionary statement regarding forward-looking statements This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise deliver value for customers and stockholders; (5) the impact and expected duration of supply chain disruptions, and our ability to mitigate them; (6) the impact of the COVID-19 pandemic on our operations and financial results, and our ability to mitigate operational and business impacts caused by it; and (7) the impact of trade regulations, export controls and trade disputes. Forward-looking statements speak only as of the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed, including: supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; trade regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and Exchange Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021 and our quarterly report on Form 10-Q for the quarter ended December 26, 2021. You should not place undue reliance on forward- looking statements. Lam undertakes no obligation to update any forward-looking statements. -- 2 of 24 -- L A M R E S E A R C H Business review & industry outlook Tim Archer President and Chief Executive Officer -- 3 of 24 -- L A M R E S E A R C H Revenue of $4.06B and EPS of $7.40 within guidance ranges Continued component shortages and new issues including those related to COVID lockdowns Lam committing investment and resources to address supply chain challenges March quarter takeaways EPS = earnings per share EPS calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation -- 4 of 24 -- L A M R E S E A R C H Confident of progressive improvements, supported by $2B in deferred revenue NEAR-TERM FOCUS LONG-TERM FOCUS Prioritizing supply chain resilience Accelerating procurement of parts Increasing field resources to complete installs Partnering with customers to qualify additional suppliers in most severely constrained areas Assigning engineering resources to improve supply chain flexibility -- 5 of 24 -- L A M R E S E A R C H WFE investment remains robust 2022 WFE view still in the $100B range, potentially limited by continued supply-related delays Unconstrained demand at over $100B Powerful long-term secular growth drivers including rising semiconductor content and increasing device complexity remain intact WFE = wafer fabrication equipment -- 6 of 24 -- L A M R E S E A R C H + Differentiated etch and deposition equipment for manufacturing higher performance and more scalable 3D device architectures + Innovative installed base products and services + Continuing investment in an exceptional pipeline of new products and services Lam-specific long-term growth drivers remain strong -- 7 of 24 -- L A M R E S E A R C H FOUNDRY-LOGIC DRAM NAND Growing Lam’s technology leadership across device segments Selective etch win at a large customer New conductor etch wins, set to double node-to-node share at key customer, leveraging Equipment Intelligence® platform capabilities Significant momentum for both ALD metals and dielectrics deposition solutions for leading-edge foundry/logic nodes Etch: Leveraged foundry-logic success to drive share growth at key customer as devices adopt High K Metal Gate transistors Deposition: Two wins at leading node for critical spacer applications Highly contested ALD win at key customer for critical wordline application ALD = atomic layer deposition -- 8 of 24 -- L A M R E S E A R C H CSBG expected to show strong growth in 2022 March quarter results down modestly due to supply chain impact on Reliant® and upgrades businesses Expanding installed base over a longer period offers stable platform for revenue growth Secured spares contracts at two of the world’s largest IDMs – cumulative contract value >$1B IDM = integrated device manufacturer -- 9 of 24 -- L A M R E S E A R C H Lam’s 2022 focus Making progress on addressing the extraordinary industry supply challenges Committing financial resources and workforce to meet critical needs of our customers Seeing continued strong demand for our equipment in a robust WFE spending environment Expect to post a solid year of revenue and EPS growth in CY 2022 -- 10 of 24 -- L A M R E S E A R C H March quarter 2022 financial results & June quarter 2022 outlook Doug Bettinger Executive Vice President and Chief Financial Officer -- 11 of 24 -- L A M R E S E A R C H Q MAR'22 REVENUE Q MAR'22 DEFERRED REVENUE March quarter results $4.06B Q Dec'21 revenue: $4.23B $2.07B Q Dec'21 deferred revenue: $1.46B -- 12 of 24 -- L A M R E S E A R C H March quarter revenue mix Record level of DRAM and Logic/Other revenue dollars Memory 66% System revenue segments* Revenue by region NVM = non-volatile memory *Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant® product line -- 13 of 24 -- L A M R E S E A R C H Q MAR'22 CSBG REVENUE Customer Support Business Group $1.41B Q Dec'21 CSBG revenue: $1.49B Q Mar'21 CSBG revenue: $1.30B -- 14 of 24 -- L A M R E S E A R C H March quarter financial results Q MAR'22 Q DEC'21 Revenue $4,060M $4,227M Non-GAAP Gross Margin* 44.7% 46.8% Non-GAAP Operating Expenses* $621M $627M Non-GAAP Operating Income* $1,194M $1,352M Non-GAAP Operating Income as a percentage of Revenue* 29.4% 32.0% Non-GAAP Other (Expense) Income, Net* $(44)M $19M U.S. GAAP Diluted EPS $7.30 $8.44 Non-GAAP Diluted EPS* $7.40 $8.53 Diluted Share Count 140M 142M *A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation. -- 15 of 24 -- L A M R E S E A R C H Key balance sheet and financial metrics Q MAR'22 Q DEC'21 Total Consolidated Gross Cash Balance $4,606M $5,580M Accounts Receivable, Net $3,702M $3,403M DSO 83 Days 73 Days Inventories $3,479M $3,074M Inventory Turns 2.6 2.9 Deferred Revenue* $2,069M $1,458M Capital Expenditures $145M $138M Equity Compensation Expense $69M $63M Amortization Expense $20M $20M Depreciation Expense $64M $62M Share Repurchases $1,200M $430M Cash Dividends $211M $211M Headcount ~16,900 ~16,300 *Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance. Estimated future revenue from shipments to customers in Japan was approximately $263M as of March 27, 2022 and $328M as of December 26, 2021. -- 16 of 24 -- L A M R E S E A R C H $4.20B +/- $300M Revenue 44.5% +/- 1% Non-GAAP gross margin 29.5% +/- 1% Non-GAAP operating margin $7.25 +/- $0.75 Non-GAAP earnings per share* June 2022 quarter guidance A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation *Based on a diluted share count of approximately 139 million shares -- 17 of 24 -- L A M R E S E A R C H Q&A -- 18 of 24 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income (in thousands, except per share data) (unaudited) Three Months Ended March 27, 2022 December 26, 2021 U.S. GAAP net income $ 1,021,778 $ 1,194,830 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 1,153 1,092 Elective deferred compensation ("EDC") related liability valuation decrease - cost of goods sold (2,868) (8) EDC related liability valuation decrease - research and development (5,161) (15) Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 12,494 12,357 EDC related liability valuation decrease - selling, general and administrative (3,441) (10) Amortization of note discounts - other income (expense), net 695 689 Loss on EDC related asset - other income (expense), net 13,118 56 Net income tax benefit on non-GAAP items (1,409) (1,651) Non-GAAP net income $ 1,036,359 $ 1,207,340 Non-GAAP net income per diluted share $ 7.40 $ 8.53 U.S. GAAP net income per diluted share $ 7.30 $ 8.44 U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 140,057 141,530 -- 19 of 24 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income (in thousands, except percentages) (unaudited) Three Months Ended March 27, 2022 December 26, 2021 U.S. GAAP gross margin $ 1,816,625 $ 1,977,916 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations 1,153 1,092 EDC related liability valuation decrease (2,868) (8) Non-GAAP gross margin $ 1,814,910 $ 1,979,000 U.S. GAAP gross margin as a percentage of revenue 44.7 % 46.8 % Non-GAAP gross margin as a percentage of revenue 44.7 % 46.8 % U.S. GAAP operating expenses $ 624,528 $ 639,777 Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations (12,494) (12,357) EDC related liability valuation decrease 8,602 25 Non-GAAP operating expenses $ 620,636 $ 627,445 U.S. GAAP operating income $ 1,192,097 $ 1,338,139 Non-GAAP operating income $ 1,194,274 $ 1,351,555 U.S. GAAP operating income as percent of revenue 29.4 % 31.7 % Non-GAAP operating income as a percent of revenue 29.4 % 32.0 % -- 20 of 24 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP Other Income (Expense), Net to Non-GAAP Other Income (Expense), Net (in thousands) (unaudited) Three Months Ended March 27, 2022 December 26, 2021 U.S. GAAP Other income (expense), net $ (57,402) $ 17,999 Pre-tax non-GAAP items: Amortization of note discounts 695 689 Loss on EDC related asset 13,118 56 Non-GAAP Other income (expense), net $ (43,589) $ 18,744 -- 21 of 24 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate (in thousands, except percentages) (unaudited) Three Months Ended March 27, 2022 December 26, 2021 U.S. GAAP income before income taxes $ 1,134,695 $ 1,356,138 U.S. GAAP income tax expense $ 112,917 $ 161,308 U.S. GAAP income tax rate 10.0 % 11.9 % Pre-tax non-GAAP items: Amortization related to intangible assets acquired through certain business combinations - cost of goods sold $ 1,153 $ 1,092 Elective deferred compensation ("EDC") related liability valuation decrease - cost of goods sold (2,868) (8) EDC related liability valuation decrease - research and development (5,161) (15) Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 12,494 12,357 EDC related liability valuation decrease - selling, general and administrative (3,441) (10) Amortization of note discounts - other income (expense), net 695 689 Loss on EDC related asset - other income (expense), net 13,118 56 Non-GAAP income before taxes $ 1,150,685 $ 1,370,299 Net income tax benefit on non-GAAP items $ 1,409 $ 1,651 Non-GAAP income tax expense $ 114,326 $ 162,959 Non-GAAP income tax rate 9.9 % 11.9 % -- 22 of 24 -- L A M R E S E A R C H Appendix – reconciliation Reconciliation of U.S. GAAP to Non-GAAP Guidance for the quarter ended June 26, 2022 The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows: • Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million. • Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $11 million. • Net income per diluted share - amortization related to intangible assets acquired though business combinations, $11 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $10 million. U.S. GAAP Reconciling Items Non-GAAP Revenue $4.20 Billion +/- $300 Million — $4.20 Billion +/- $300 Million Gross margin as a percentage of revenue 44.5% +/- 1% $ 1 Million 44.5% +/- 1% Operating income as a percentage of revenue 29.2% +/- 1% $ 11 Million 29.5% +/- 1% Net income per diluted share $7.18 +/- $0.75 $ 10 Million $7.25 +/- $0.75 Diluted share count 139 Million — 139 Million -- 23 of 24 -- -- 24 of 24 --